These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8781382)
1. Cigarette smoking and p53 mutations in lung cancer and bladder cancer. Husgafvel-Pursiainen K; Kannio A Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):553-6. PubMed ID: 8781382 [TBL] [Abstract][Full Text] [Related]
2. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [TBL] [Abstract][Full Text] [Related]
3. p53 and K-ras mutations in lung cancers from former and never-smoking women. Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059 [TBL] [Abstract][Full Text] [Related]
4. Influence of cigarette smoking on P53 gene mutations in bladder carcinomas. Bernardini S; Adessi GL; Chezy E; Billerey C; Carbillet JP; Bittard H Anticancer Res; 2001; 21(4B):3001-4. PubMed ID: 11712801 [TBL] [Abstract][Full Text] [Related]
5. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer. Husgafvel-Pursiainen K; Boffetta P; Kannio A; Nyberg F; Pershagen G; Mukeria A; Constantinescu V; Fortes C; Benhamou S Cancer Res; 2000 Jun; 60(11):2906-11. PubMed ID: 10850436 [TBL] [Abstract][Full Text] [Related]
6. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Spruck CH; Rideout WM; Olumi AF; Ohneseit PF; Yang AS; Tsai YC; Nichols PW; Horn T; Hermann GG; Steven K Cancer Res; 1993 Mar; 53(5):1162-6. PubMed ID: 8439962 [TBL] [Abstract][Full Text] [Related]
7. A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database. Hernandez-Boussard TM; Hainaut P Environ Health Perspect; 1998 Jul; 106(7):385-91. PubMed ID: 9637795 [TBL] [Abstract][Full Text] [Related]
8. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Habuchi T; Takahashi R; Yamada H; Ogawa O; Kakehi Y; Ogura K; Hamazaki S; Toguchida J; Ishizaki K; Fujita J Cancer Res; 1993 Aug; 53(16):3795-9. PubMed ID: 8339293 [TBL] [Abstract][Full Text] [Related]
9. Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Hainaut P; Pfeifer GP Carcinogenesis; 2001 Mar; 22(3):367-74. PubMed ID: 11238174 [TBL] [Abstract][Full Text] [Related]
10. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung. Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Conway K; Edmiston SN; Cui L; Drouin SS; Pang J; He M; Tse CK; Geradts J; Dressler L; Liu ET; Millikan R; Newman B Cancer Res; 2002 Apr; 62(7):1987-95. PubMed ID: 11929815 [TBL] [Abstract][Full Text] [Related]
12. A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos. Kannio A; Ridanpää M; Koskinen H; Partanen T; Anttila S; Collan Y; Hietanen E; Vainio H; Husgafvel-Pursiainen K Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):33-9. PubMed ID: 8770464 [TBL] [Abstract][Full Text] [Related]
13. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers. Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742 [TBL] [Abstract][Full Text] [Related]
14. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Pfeifer GP; Denissenko MF; Olivier M; Tretyakova N; Hecht SS; Hainaut P Oncogene; 2002 Oct; 21(48):7435-51. PubMed ID: 12379884 [TBL] [Abstract][Full Text] [Related]
15. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551 [TBL] [Abstract][Full Text] [Related]
16. P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers. LaRue H; Allard P; Simoneau M; Normand C; Pfister C; Moore L; Meyer F; Têtu B; Fradet Y Carcinogenesis; 2000 Jan; 21(1):101-6. PubMed ID: 10607740 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers. Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921 [TBL] [Abstract][Full Text] [Related]
18. Human lung cancer and p53: the interplay between mutagenesis and selection. Rodin SN; Rodin AS Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12244-9. PubMed ID: 11035769 [TBL] [Abstract][Full Text] [Related]
19. p53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking. Takagi Y; Osada H; Kuroishi T; Mitsudomi T; Kondo M; Niimi T; Saji S; Gazdar AF; Takahashi T; Minna JD; Takahashi T Br J Cancer; 1998 May; 77(10):1568-72. PubMed ID: 9635830 [TBL] [Abstract][Full Text] [Related]
20. Tobacco and cancer: epidemiology and the laboratory. Vineis P; Caporaso N Environ Health Perspect; 1995 Feb; 103(2):156-60. PubMed ID: 7737063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]